Journal of International Reproductive Health/Family Planning ›› 2022, Vol. 41 ›› Issue (5): 365-369.doi: 10.12280/gjszjk.20220103

• Original Article • Previous Articles     Next Articles

Clinical Application of Chromosome Microarray Analysis in Fetuses with Talipes Equinovarus

LUO Xiao-hui, ZHOU Wei-ning, LI Yi, REN Cong-mian, HUANG Yan-lin, LU Jian()   

  1. Medical Genetics Center, Guangdong Women and Children′s Hospital and Health Institute, Maternal and Children Metabolic-Genetic Key Laboratory, Guangzhou 511400, China
  • Received:2022-02-24 Published:2022-09-15 Online:2022-10-12
  • Contact: LU Jian E-mail:243561205@qq.com

Abstract:

Objective: To evaluate the clinical value of chromosome microarray analysis (CMA) in the fetuses with talipes equinovarus (TE). Methods: We retrospectively collected the clinic data of 157 cases of TE fetuses from January 2016 to July 2020 who were diagnosed by ultrasound and tested by CMA. The fetuses were then divided into two groups as the isolated TE group (107 cases) and the complex TE group (50 cases). The positive rate of chromosomal variations in each group was analyzed. The positive rates of clinically significant copy number variation (CNV) of the two groups were compared with the risk ratio of low-risk pregnancy cohorts, to analyze whether the risk was enriched in TE fetuses. Results: ①The total positive rate of clinically significant chromosomal variations of TE fetuses was 10.19% (16/157), the positive rate of chromosome aneuploidy was 5.73% (9/157), the positive rate of CNV was 6.37% (10/157), in which the positive rate of clinically significant CNV was 4.46% (7/157). There were no significant differences in the positive rate of clinically significant chromosomal variation, the positive rate of chromosome aneuploidy and the positive rate of clinically significant CNV between the two groups(P>0.05). ② The total positive rate of clinically significant CNV in the TE fetuses and the positive rate of clinically significant CNV in the isolated TE group were significantly higher than those in the low- risk pregnancy cohort, respectively (P<0.05). There was no significant difference in the positive rate of clinically significant CNV between the complex TE group and the low- risk pregnancy cohort (P>0.05). Conclusions: The risk of clinically significant CNV in the TE fetuses is significantly higher than that in the low-risk pregnancy population. CMA can improve the detection rate of CNV in the fetuses with TE by about 6% (10/157), while CMA has important clinical value in detecting chromosomal microdeletion/microduplication in the TE fetus.

Key words: Talipes equinovarus, Fetus, Chromosomes, DNA copy number variations, Aneuploidy, Prenatal diagnosis, Ultrasonography, Chromosome microarray analysis